Viewing Study NCT04290793


Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2025-12-25 @ 11:17 PM
Study NCT ID: NCT04290793
Status: UNKNOWN
Last Update Posted: 2020-03-02
First Post: 2020-02-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer
Sponsor: Hebei Medical University Fourth Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module